(Q37038371)

17 August 2017

1 reference

title

Statins and polyunsaturated fatty acids for treatment of atrial fibrillation (English)

1 reference

17 August 2017

0 references

0 references

1

Irina Savelieva

1 reference

17 August 2017

John Camm

2

1 reference

17 August 2017

publication date

1 January 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

17 August 2017

published in

1 reference

17 August 2017

volume

5

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

30-41

1 reference

Pathophysiology and prevention of atrial fibrillation

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

Histological substrate of atrial biopsies in patients with lone atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

Uric acid and prognosis in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

'Atrial fibrillation--an end to the epidemic?'.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Mechano-electric feedback and atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Intra-Atrial Pressure Increases Rate and Organization of Waves Emanating From the Superior Pulmonary Veins During Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Gadolinium decreases stretch-induced vulnerability to atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Tarantula peptide inhibits atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

A multicenter risk index for atrial fibrillation after cardiac surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Effect of C-reactive protein reduction on paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Inflammation as a risk factor for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

C-Reactive protein in lone atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

The effects of atrial fibrillation on atrial pressure-volume and flow relationships

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Matrix metalloproteinases and atrial structural remodeling

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Nitric oxide regulates the calcium current in isolated human atrial myocytes.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Association of statin therapy and the risk of atrial fibrillation in patients with a permanent pacemaker.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Dietary fish oil protects against stretch-induced vulnerability to atrial fibrillation in a rabbit model

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

n-3 (omega-3) polyunsaturated fatty acids prevent acute atrial electrophysiological remodeling

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Fish intake and risk of incident atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1038

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1038

1 reference

17 August 2017

1 reference